ArticleCase reports in oncology
Kaposi Sarcoma Presenting as Retroperitoneal Lymphadenopathy: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Kaposi sarcoma is a mesenchymal vascular tumor caused by human gammaherpesvirus 8. Kaposi sarcoma is typically associated with immunocompromise and HIV, and has a classical form seen in elderly men of Mediterranean or Eastern European ethnic origin. We herein present an atypical case of Kaposi sarcoma presenting as retroperitoneal adenopathy in an immunocompetent, non-Mediterranean patient. Case Presentation: A previously healthy 53-year-old patient presented to the emergency department with lower abdominal pain and was found to have isolated retroperitoneal lymphadenopathy on abdominal imaging, later confirmed to be Kaposi sarcoma on biopsy. The patient presented without typical cutaneous findings of Kaposi sarcoma or any risk factors for the disease, including HIV, immunocompromise, or Mediterranean descent. The patient was referred to medical oncology and has had spontaneous regression of adenopathy in the absence of any treatment. Conclusion: Our review of the case and of the literature demonstrates the many atypical ways in which KS can present. Our case highlights the importance of considering KS in the differential diagnosis for visceral lymphadenopathy in the absence of solid tumor pathology. Lastly, our case brings to light the variable clinical course of KS, which can range from minimal to explosive growth to spontaneous regression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.